PRESS RELEASE published on 12/05/2023 at 16:00, 1 year 3 months ago First Light Diagnostics Receives FDA Clearance for its Rapid B. anthracis Toxin Test on the MultiPath Analyzer First Light Diagnostics receives FDA clearance for its SensiTox B. anthracis Toxin Test, a 20-minute, sensitive immunofluorescence assay for early detection of inhalation anthrax, marking a significant advancement in biodefense and public health FDA Clearance First Light Diagnostics SensiTox B. Anthracis Toxin Test Inhalation Anthrax Biodefense
Published on 04/03/2025 at 15:05, 6 hours 5 minutes ago Snowline Gold Closes Fully Subscribed C$20 Million Financing Of Flow-Through Shares
Published on 04/03/2025 at 15:00, 6 hours 10 minutes ago Kingstone Insurance Partners with Kyber Technologies Inc.
Published on 04/03/2025 at 15:00, 6 hours 10 minutes ago UniDoc Announces Debt Settlement and Renews Marketing Engagement
Published on 04/03/2025 at 15:00, 6 hours 10 minutes ago Xebra Brands’ Largest Shareholder Increases Stake as Company Explores Landmark Agricultural Agreement in Mexico
Published on 04/03/2025 at 14:30, 6 hours 40 minutes ago Dominari Holdings Highlights Supporting American Companies
Published on 04/03/2025 at 18:46, 2 hours 24 minutes ago Monthly disclosure of the total number of shares and voting rights - March 2025
Published on 04/03/2025 at 18:46, 2 hours 24 minutes ago Déclaration mensuelle des actions et droits de vote – Mars 2025
Published on 04/03/2025 at 18:00, 3 hours 10 minutes ago LDC : Chiffre d'affaires 2024-2025 : 6,3 milliards d’euros, au-delà des objectifs.
Published on 04/03/2025 at 17:45, 3 hours 25 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
